Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Investigations

A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*

Vincent, Jean-Louis MD, PhD; Artigas, Antonio MD, PhD; Petersen, Lars C. PhD, DSc; Meyer, Christian MD, PhD

Author Information
doi: 10.1097/CCM.0b013e31819fff2c
  • Buy


© 2009 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins